Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

VERTEX PHARMS INC

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 21
  • 0 comments

FDA approve IVACAFTOR; LUMACAFTOR

Comment Full text

IMPAX LABS

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 25
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 23
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 23
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

VERTEX PHARMS INC

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 22
  • 0 comments

FDA approve IVACAFTOR; LUMACAFTOR

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 23
  • 0 comments

FDA approve OFATUMUMAB

Comment Full text

BAYER HEALTHCARE PHARMS

  • FDA Approval
  • Sept. 05, 2022, 23:36 UTC
  • 22
  • 0 comments

FDA approve INTERFERON BETA-1B

Comment Full text

ASTRAZENECA UK LTD

  • FDA Approval
  • Sept. 02, 2022, 09:30 UTC
  • 28
  • 0 comments

FDA approve DURVALUMAB

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 02, 2022, 06:40 UTC
  • 27
  • 0 comments

FDA approve PEGFILGRASTIM

Comment Full text

BOEHRINGER INGELHEIM PHARMACEUTICALS INC

  • FDA Approval
  • Sept. 02, 2022, 06:33 UTC
  • 25
  • 0 comments

FDA approve SPESOLIMAB

Comment Full text
  • Previous
  • 997
  • 998
  • 999
  • 1000
  • 1001
  • Next

Search

News categories

  • Technical Exchange News(12370)
  • Event(6229)
  • SEC News(271828)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158072)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin